Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new release/patch was applied. This update relates to site metadata rather than changes to study data or visible content.
    Difference
    0.0%
    Check dated 2026-05-18T03:46:53.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays an updated “Revision” version number for the ClinicalTrials.gov interface (from v3.5.2 to v3.5.3). This represents a platform/version update rather than a modification to the trial record itself.
    Difference
    0.0%
    Check dated 2026-04-26T15:13:39.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the history log.
    Difference
    0.0%
    Check dated 2026-04-19T12:44:28.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.
    Difference
    0.0%
    Check dated 2026-03-21T08:47:03.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.4.3, was added and the previous Revision: v3.4.2 entry was removed.
    Difference
    0.0%
    Check dated 2026-03-06T21:00:32.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:14:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.